S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Repros Updates Androxal(R) Global Regulatory Status (2014/12/29)|
|Catalyst Pharmaceuticals Provides an Update of 2015 Goals for Its Product Portfolio (2015/1/12)|
|Puma Biotechnology Updates Timeline for Filing New Drug Application (2014/12/2)|
|Catalyst Pharmaceuticals Announces Encouraging Pre-NDA Meeting With the FDA for Firdapse(TM) as a Treatment for Lambert-Eaton Myasthenic Syndrome (LEMS) (2015/2/2)|
|Endo Pharmaceuticals and BioDelivery Sciences Announce Acceptance of NDA for BELBUCA™ (buprenorphine HCl) Buccal Film for the Management of Chronic Pain (2015/2/23)|
|Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain (2014/12/23)|
|Otonomy Provides Corporate and Product Pipeline Update (2015/1/8)|
|Celator® Pharmaceuticals Receives FDA Fast Track Designation For CPX-351 For The Treatment Of Elderly Patients With Secondary Acute Myeloid Leukemia (2015/1/20)|
|INVESTOR ALERT: Investigation of Puma Biotechnology, Inc. Announced by Glancy Binkow & Goldberg LLP (2014/12/9)|
|Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer (2015/1/5)|
Click above to view more mutual fund data and stats for nda - Aurubis AG.